Rx Partners Pharmacy Dallas Dallas, TX - 75219

Rx Partners Pharmacy Dallas is categorized under Wholesale Pharmaceutical Products in Dallas, TX and active since 2010.

Rx Partners Pharmacy Dallas was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Michael Mcbride at the company’s single location by writing to 2924 Oak Lawn Avenue, Dallas, Texas TX 75219 or by phoning (214) 780-0898. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Rx Partners Pharmacy Dallas
Contact Person: Michael Mcbride
Address: 2924 Oak Lawn Avenue, Dallas, Texas 75219
Phone Number: (214) 780-0898
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Rx Partners Pharmacy Dallas was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Michael Mcbride for inquiries that concern Rx Partners Pharmacy Dallas by calling the company number (214) 780-0898, as your correspondence is most welcome. Additionally, the physical location of the single location of Rx Partners Pharmacy Dallas can be found at the coordinates 32.808116,-96.809349 as well as the street address 2924 Oak Lawn Avenue in Dallas, Texas 75219.

For its online presence, you may visit Rx Partners Pharmacy Dallas’s website at and engage with its social media outlets through on Twitter and on Facebook.